BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-14.73%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$5.16B
AUM Growth
+$5.16B
(-18%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
40.75%
Holding
231
New
16
Increased
80
Reduced
52
Closed
17
Top Buys
| 1 |
Black Diamond Therapeutics
BDTX
|
$33.2M |
| 2 |
Fate Therapeutics
FATE
|
$32.9M |
| 3 |
Intuitive Surgical
ISRG
|
$21.8M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$21.5M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$21M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$85.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$49.3M |
| 3 |
Moderna
MRNA
|
$29.5M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$27.6M |
| 5 |
QuidelOrtho
QDEL
|
$21.9M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.54% |
| 4 | Communication Services | 0.17% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amgen
AMGN
$154B
| $26.7M | 0.52% |
131,573
+91,223
| +226% | +$18.5M |
|
52
Insmed
INSM
$30.7B
| $25.9M | 0.5% |
1,613,470
+29,910
| +2% | +$479K |
|
53
Q32 Bio
QTTB
$20.9M
| $25.1M | 0.49% |
1,612,122
| – | – |
|
54
Voyager Therapeutics
VYGR
$199M
| $24.9M | 0.48% |
2,724,083
+19,800
| +0.7% | +$181K |
|
55
Evolent Health
EVH
$1.11B
| $24.9M | 0.48% |
4,580,458
+1,031,845
| +29% | +$5.6M |
|
56
HCA Healthcare
HCA
$95B
| $24.5M | 0.48% |
272,966
+20,338
| +8% | +$1.83M |
|
57
Sangamo Therapeutics
SGMO
$163M
| $24.5M | 0.48% |
3,850,000
| – | – |
|
58
Wave Life Sciences
WVE
$1.53B
| $24.4M | 0.47% |
2,602,858
+200,000
| +8% | +$1.87M |
|
59
Teleflex
TFX
$5.61B
| $22.9M | 0.44% |
78,333
+3,614
| +5% | +$1.06M |
|
60
Pacific Biosciences
PACB
$384M
| $22.6M | 0.44% |
7,378,791
+1,644,482
| +29% | +$5.03M |
|
|
GWPH
61
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $22M | 0.43% |
250,966
+239,766
| +2,141% | +$21M |
|
62
Bio-Rad Laboratories Class A
BIO
$7.87B
| $21.9M | 0.42% |
62,373
+15,588
| +33% | +$5.46M |
|
63
Hologic
HOLX
$14.8B
| $19.9M | 0.39% |
567,779
+306,000
| +117% | +$10.7M |
|
64
Molina Healthcare
MOH
$9.93B
| $17.9M | 0.35% |
128,206
-2,413
| -2% | -$337K |
|
65
Insulet
PODD
$24.3B
| $17M | 0.33% |
102,350
+920
| +0.9% | +$152K |
|
66
Masimo
MASI
$7.48B
| $16.3M | 0.32% |
92,245
+13,196
| +17% | +$2.34M |
|
|
ABMD
67
DELISTED
Abiomed Inc
ABMD
| $15.7M | 0.3% |
108,072
+20,233
| +23% | +$2.94M |
|
68
Kezar Life Sciences
KZR
$28M
| $15.3M | 0.3% |
3,518,889
+1,968,220
| +127% | +$8.58M |
|
69
HUTCHMED
HCM
$2.63B
| $15.2M | 0.29% |
851,994
+34,177
| +4% | +$610K |
|
|
HMSY
70
DELISTED
HMS Holdings Corp.
HMSY
| $14.5M | 0.28% |
575,177
+57,800
| +11% | +$1.46M |
|
71
Globus Medical
GMED
$8.09B
| $14.4M | 0.28% |
338,067
+230
| +0.1% | +$9.78K |
|
72
Penumbra
PEN
$10.5B
| $13.3M | 0.26% |
82,139
+13,284
| +19% | +$2.14M |
|
73
Omnicell
OMCL
$1.47B
| $12.9M | 0.25% |
196,136
-203
| -0.1% | -$13.3K |
|
74
Glaukos
GKOS
$5.39B
| $12.7M | 0.25% |
412,623
+10,475
| +3% | +$323K |
|
75
CVS Health
CVS
$94B
| $12.6M | 0.25% |
212,981
+5,702
| +3% | +$338K |
|